CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1 Dose ...

Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found ...

By using a protein called Cas9 to find and remove a damaged portion of a genetic sequence and then replace it using a ...

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...

The candy giant is using Pairwise’s plant-breeding technology to improve cocoa production as climate challenges and disease ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

A team from UC San Diego, John Hopkins and UC Berkeley Universities found a way to edit a single gene in a mosquito that ...

CRISPR Therapeutics AG stock has soared 90% since May, driven by Casgevy approval and future breakthroughs in gene editing. Click for my CRSP stock update.

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology. By Rebecca Sohn Updated Jul 28, 2021 5:01 PM EDT Get the Popular Science ...